Flagship Pioneering Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Flagship pioneering inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Flagship Pioneering Inc Today - Breaking & Trending Today

Syros Pharmaceuticals (NASDAQ:SYRS) Shares Cross Below 50-Day Moving Average of $5.25

Shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $5.25 and traded as low as $4.99. Syros Pharmaceuticals shares last traded at $5.00, with a volume of 68,625 shares trading hands. Analyst Upgrades and Downgrades […] ....

Piper Sandler , Syros Pharmaceuticals , Hedge Funds Weigh In On Syros Pharmaceuticals , Syros Pharmaceuticals Inc , Syros Pharmaceuticals Company Profile , Flagship Pioneering Inc , News Ratings For Syros Pharmaceuticals Daily , Bain Capital Life Sciences Investors , Syros Pharmaceuticals Stock , Get Free Report , Partners Management , Capital Life Sciences Investors , Flagship Pioneering , Syros Pharmaceuticals Daily ,

Meatable Appoints Jeff Tripician as New CEO | Company Announcement

Investegate announcements from Meatable Appoints Jeff Tripician as New CEO ....

Michael Johnson , Jim Mellon , Mark Kotter , Charles Goodfellow , Meatablebv Meatable , Bob Huxford , Jeff Tripician , James Biddle , Andrew Potts , Anthony Hughes , Roland Cornish , Lucy Williams , Harry Pardoe , Giles Balleny , Flagship Pioneering Inc , Perdue Farms Inc , Sunfed Beef , Cavendish Capital Markets , Teton Waters Ranch , Grassfed Foods , Canaccord Genuity , Indigo Ag Inc , Tyson Foods Inc , Lx Development , Appoints Jeff Tripician , Krijn De Nood ,

Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5.94

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 and traded as low as $5.28. Syros Pharmaceuticals shares last traded at $5.44, with a volume of 199,560 shares traded. Wall Street Analysts […] ....

Piper Sandler , Syros Pharmaceuticals Inc , Syros Pharmaceuticals Trading , Opaleye Management Inc , News Ratings For Syros Pharmaceuticals Daily , Syros Pharmaceuticals , Flagship Pioneering Inc , Institutional Trading Of Syros Pharmaceuticals , Syros Pharmaceuticals Company Profile , Get Free Report , Partners Management , Flagship Pioneering , Syros Pharmaceuticals Daily , Nasdaq Syrs ,

Top Moderna Shareholders

The top institutional shareholders of Moderna are Baillie Gifford & Co., Vanguard Group Inc., and BlackRock Inc.. ....

United Kingdom General , United Kingdom , New York , United States , City Of , Noubar Afeyan , Stephen Hoge , Noubarb Afeyan , Baillie Gifford , Baillie Gifford Co , Vanguard Total Stock Market Index Fund , Flagship Pioneering Inc , Moderna Inc , Blackrock Inc , Mckinsey Co , Vanguard Group Inc , Vanguard International Growth Fund , Eli Lilly Co , Index Fund , Insider Shareholders , Eli Lilly , Much Does Moderna Spend ,

Syros Pharmaceuticals (NASDAQ:SYRS) Downgraded by StockNews.com

StockNews.com lowered shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a hold rating to a sell rating in a research report released on Friday. Several other research firms also recently commented on SYRS. Piper Sandler reaffirmed an overweight rating and set a $13.00 price objective on shares of Syros Pharmaceuticals in a report on […] ....

Piper Sandler , Syros Pharmaceuticals , Syros Pharmaceuticals Stock Performance , Flagship Pioneering Inc , Blue Owl Capital Holdings , Goldman Sachs Group Inc , Syros Pharmaceuticals Inc , News Ratings For Syros Pharmaceuticals Daily , Vanguard Group Inc , Opaleye Management Inc , Free Report , Sachs Group , Owl Capital Holdings , Flagship Pioneering , Get Free Report , Syros Pharmaceuticals Daily , Nasdaq Syrs , Stocknews Com ,